Skip to main content
. 2022 May 17;45(5):535–548. doi: 10.1007/s40264-022-01153-8

Table 1.

Patient and report characteristics

ADR identification task Seriousness assessment task
Development dataset
(n = 10,403)
External validation dataset
(n = 1230)
Development dataset
(n = 4786)
External validation dataset
(n = 404)
Patient age, years
 Median (IQR) 51 (37–62) 51 (39–63) 41 (30–58) 39 (31–56)
Patient sex, n (%)
 Female 8792 (84.5) 1056 (85.9) 3732 (78.0) 313 (77.5)
Encoded PTs per report, n
 Median (IQR) 4 (2–6) 5 (3–7) 3 (1–5) 3 (2–6)
Reported drugs per report, n
 Median (IQR) 1 (1–1) 1 (1–1) 1 (1–1) 1 (1–1)
Reports about vaccines, n (%)
 Yes 275 (2.6) 13 (1.1) 275 (5.7) 13 (3.2)
Reports considered serious, n (%)
 Yes 2454 (23.6) 136 (11.1) 1128 (23.6) 84 (20.8)

ADRs adverse drug reactions, IQR interquartile range, PTs Preferred Terms